T. Rowe Price Associates’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390M Buy
1,763,135
+1,417,618
+410% +$347M 0.05% 302
2025
Q4
$87.6M Buy
345,517
+88,416
+34% +$22.2M 0.01% 665
2025
Q3
$63.6M Buy
257,101
+6,809
+3% +$1.63M 0.01% 724
2025
Q2
$60.1M Sell
250,292
-239
-0.1% -$55.6K 0.01% 688
2025
Q1
$56.8M Sell
250,531
-15,131
-6% -$3.33M 0.01% 689
2024
Q4
$54.6M Sell
265,662
-119,727
-31% -$26.3M 0.01% 724
2024
Q3
$93.5M Sell
385,389
-35,773
-8% -$8.37M 0.01% 584
2024
Q2
$92.5M Sell
421,162
-1,317,468
-76% -$286M 0.01% 560
2024
Q1
$391M Buy
1,738,630
+120,616
+7% +$27.2M 0.05% 317
2023
Q4
$356M Buy
1,618,014
+85,305
+6% +$18M 0.05% 310
2023
Q3
$336M Sell
1,532,709
-436,182
-22% -$98.7M 0.05% 299
2023
Q2
$443M Sell
1,968,891
-318,142
-14% -$63.7M 0.06% 267
2023
Q1
$437M Sell
2,287,033
-77,250
-3% -$14.9M 0.07% 258
2022
Q4
$437M Buy
2,364,283
+107,474
+5% +$18.9M 0.07% 253
2022
Q3
$375M Sell
2,256,809
-135,382
-6% -$27.5M 0.06% 262
2022
Q2
$493M Sell
2,392,191
-660,362
-22% -$149M 0.06% 293
2022
Q1
$738M Buy
3,052,553
+1,721,583
+129% +$399M 0.07% 257
2021
Q4
$324M Buy
1,330,970
+554,538
+71% +$127M 0.03% 437
2021
Q3
$159M Buy
776,432
+194,100
+33% +$41.5M 0.01% 624
2021
Q2
$120M Buy
582,332
+374,386
+180% +$75.4M 0.01% 720
2021
Q1
$39.6M Sell
207,946
-9,060
-4% -$1.68M ﹤0.01% 1084
2020
Q4
$41.1M Sell
217,006
-6,561
-3% -$1.22M ﹤0.01% 1024
2020
Q3
$39.4M Sell
223,567
-3,947
-2% -$631K ﹤0.01% 952
2020
Q2
$34.9M Sell
227,514
-38,365
-14% -$5.84M ﹤0.01% 971
2020
Q1
$37.2M Buy
265,879
+47,197
+22% +$7.06M 0.01% 884
2019
Q4
$33.3M Sell
218,682
-114,886
-34% -$16.8M ﹤0.01% 1036
2019
Q3
$48.2M Sell
333,568
-774,510
-70% -$116M 0.01% 885
2019
Q2
$165M Sell
1,108,078
-4,581
-0.4% -$612K 0.02% 509
2019
Q1
$142M Sell
1,112,659
-29,885
-3% -$3.52M 0.02% 543
2018
Q4
$122M Sell
1,142,544
-7,276
-0.6% -$812K 0.02% 558
2018
Q3
$132M Sell
1,149,820
-47,744
-4% -$5.4M 0.02% 596
2018
Q2
$126M Sell
1,197,564
-19,270
-2% -$1.94M 0.02% 597
2018
Q1
$114M Sell
1,216,834
-26,942
-2% -$2.45M 0.02% 611
2017
Q4
$109M Sell
1,243,776
-109,247
-8% -$9.75M 0.02% 615
2017
Q3
$120M Sell
1,353,023
-170,087
-11% -$14.4M 0.02% 578
2017
Q2
$124M Sell
1,523,110
-134,848
-8% -$10.2M 0.02% 539
2017
Q1
$115M Buy
1,657,958
+72,457
+5% +$5.01M 0.02% 559
2016
Q4
$107M Sell
1,585,501
-30,520
-2% -$2.07M 0.02% 580
2016
Q3
$118M Buy
1,616,021
+5,010
+0.3% +$354K 0.02% 537
2016
Q2
$111M Buy
1,611,011
+3,280
+0.2% +$230K 0.02% 541
2016
Q1
$114M Buy
1,607,731
+11,600
+0.7% +$785K 0.02% 515
2015
Q4
$120M Sell
1,596,131
-8,580
-0.5% -$620K 0.03% 515
2015
Q3
$104M Buy
1,604,711
+9,460
+0.6% +$625K 0.02% 560
2015
Q2
$103M Sell
1,595,251
-22,850
-1% -$1.54M 0.02% 592
2015
Q1
$114M Buy
1,618,101
+10,030
+0.6% +$662K 0.02% 574
2014
Q4
$104M Sell
1,608,071
-21,560
-1% -$1.33M 0.02% 610
2014
Q3
$87.9M Sell
1,629,631
-44,500
-3% -$2.42M 0.02% 639
2014
Q2
$89.5M Sell
1,674,131
-51,080
-3% -$2.63M 0.02% 670
2014
Q1
$82.4M Sell
1,725,211
-73,010
-4% -$3.42M 0.02% 690
2013
Q4
$86.4M Buy
1,798,221
+139,430
+8% +$6.37M 0.02% 656
2013
Q3
$71.3M Buy
1,658,791
+436,700
+36% +$19M 0.02% 686
2013
Q2
$52.4M Buy
+1,222,091
New +$52.6M 0.01% 772

Other funds holding STE

T. Rowe Price Associates's STE Position: Q1 2026 in Review

T. Rowe Price Associates increased its Steris (STE) stake by 410% in Q1 2026, buying an estimated $347M and bringing the position to 1,763,135 shares worth $390M. The position accounts for 0.05% of the portfolio, ranked #302.

T. Rowe Price Associates first reported a position in STE in Q2 2013 and has held it in 52 quarters since. The position peaked at $738M in Q1 2022. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • T. Rowe Price Associates held 1,763,135 shares of Steris worth $390M as of Q1 2026.
  • T. Rowe Price Associates bought 1,417,618 Steris shares in Q1 2026, an estimated $347M.
  • Steris made up 0.05% of T. Rowe Price Associates's portfolio in Q1 2026, its #302 holding.
  • T. Rowe Price Associates first reported a position in Steris in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Steris position peaked at $738M in Q1 2022.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.